Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition

Larissa J. Mooney*, Yuhui Zhu, Caroline Yoo, Jonathan Valdez, Kevin Moino, Jung Yu Liao, Yih Ing Hser

*此作品的通信作者

研究成果: 雜誌貢獻期刊論文同行評審

15 引文 斯高帕斯(Scopus)

摘要

Treatment for substance use disorders has traditionally been abstinence-oriented, but evaluating the merits of low-level cannabis use as potential treatment endpoint may identify benefits that are clinically relevant for treatment-seeking individuals who do not attain abstinence. This study explores if reduction in cannabis use to a lower level of use is related to improved physical health, mental health, and perceived cognitive functions. Study participants with a history of problematic cannabis use (n = 111) completed assessments. Regression models were used to explore the relationship between past 30-day cannabis use levels (abstinent [57%], low use [22%] defined as less than or equal to 3 days per week, and heavy use [22%] defined as 4 or more days of use per week) and functional status in physical health, mental health, and cognition. Compared to heavy users, both abstinent and low-use individuals were similarly associated with better global health, appetite, and depression outcomes. Abstinent users also reported improved sleep, anxiety, and self-reported cognitive functioning relative to heavy users. Thus, reduction in cannabis use to lower levels is associated with beneficial outcomes important to health and other areas of functioning in individuals with problematic cannabis use.

原文英語
頁(從 - 到)479-487
頁數9
期刊Journal of NeuroImmune Pharmacology
13
發行號4
DOIs
出版狀態已發佈 - 2018 12月 1

ASJC Scopus subject areas

  • 神經科學(雜項)
  • 免疫學和過敏
  • 免疫學
  • 藥理

指紋

深入研究「Reduction in Cannabis Use and Functional Status in Physical Health, Mental Health, and Cognition」主題。共同形成了獨特的指紋。

引用此